Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). (Q37606149)

21 August 2017

1 reference

title

Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). (English)

1 reference

21 August 2017

1

1 reference

21 August 2017

G Sighinolfi

2

1 reference

21 August 2017

D Radi

3

1 reference

21 August 2017

C Argento

4

1 reference

21 August 2017

E Baraldi

5

1 reference

21 August 2017

A Carducci Artenisio

6

1 reference

21 August 2017

G Stabile

7

1 reference

21 August 2017

A Volpe

8

1 reference

21 August 2017

publication date

30 September 2009

1 reference

Human Reproduction Update

21 August 2017

published in

1 reference

21 August 2017

volume

16

1 reference

21 August 2017

issue

2

1 reference

21 August 2017

page(s)

113-130

1 reference

Estradiol and regulation of anti-Müllerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles' fluid.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Serum anti-mullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

A systematic review of tests predicting ovarian reserve and IVF outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone and ovarian dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Components of the anti-Müllerian hormone signaling pathway in gonads

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Young age does not protect against the adverse effects of reduced ovarian reserve--an eight year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Müllerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Per-follicle measurements indicate that anti-müllerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Impact of overweight and underweight on assisted reproduction treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Early follicular antimüllerian hormone as an indicator of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Association of anti-mullerian hormone levels with obesity in late reproductive-age women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

The significance of anti-Müllerian hormone concentration in seminal plasma for spermatogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Relevance of anti-Mullerian hormone measurement in a routine IVF program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone levels in serum from human foetuses and children: pattern and clinical interest

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Male sex determination: current concepts of male sexual differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Serum anti-Müllerian hormone levels do not predict the efficiency of testicular sperm retrieval in men with non-obstructive azoospermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Serum anti-Müllerian hormone and inhibin B levels at ovulation triggering day can predict the number of immature oocytes retrieved in in vitro fertilization cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone concentrations in maternal serum during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Serum anti-Mullerian hormone throughout the human menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Mullerian hormone (AMH): what do we still need to know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Mullerian inhibiting substance in humans: normal levels from infancy to adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Poor responder protocols for in-vitro fertilization: options and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Ontogeny of reproductive abnormalities induced by deregulation of anti-müllerian hormone expression in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

The science behind 25 years of ovarian stimulation for in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Antimüllerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Seminal plasma anti-Müllerian hormone level correlates with semen parameters but does not predict success of testicular sperm extraction (TESE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

The role of mullerian inhibiting substance in female reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Prognostic assessment of female fecundity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Actions of anti-Mullerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

The use of GnRH antagonists in ovarian stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-müllerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-müllerian hormone in children with androgen insensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Effect of anti-Mullerian hormone on Sertoli and Leydig cell functions in fetal and immature rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

The probability of successful IVF outcome after poor ovarian response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Analysis of serum levels of anti-Mullerian hormone, inhibin B, insulin-like growth factor-I, insulin-like growth factor binding protein-3, and follicle-stimulating hormone with respect to age and menopausal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Body size affects measures of ovarian reserve in late reproductive age women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Clinical management of low ovarian response to stimulation for IVF: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone: its role in follicular growth initiation and survival and as an ovarian reserve marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

The effect of weight loss on anti-Müllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-mullerian hormone as a marker of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone in men with normal and reduced sperm concentration and men with maldescended testes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Relationship of serum antimüllerian hormone concentration to age at menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Mild ovarian stimulation for IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

AMH signaling: from receptor to target gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone and folliculogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Müllerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Formation and early development of follicles in the polycystic ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Physical Activity, Body Mass Index, and Ovulatory Disorder Infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Abnormal sexual development in transgenic mice chronically expressing Müllerian inhibiting substance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

Anti-Müllerian hormone is a functional marker of foetal Sertoli cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMP036

21 January 2018

Identifiers

DOI

10.1093/HUMUPD/DMP036

1 reference

21 August 2017

1 reference